Connect with us

Health

Immune tolerance in hemophilia can be modulated by B cell activating factor – News-Medical.Net

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people…

Published

on

Article feature image
ADVERTISEMENT

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A.
Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII).
Both children and adults with hemophilia A (80 percent of all hemophilia) receive treatment that involves infusing FVIII protein…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Third of UK adults fully vaccinated against Covid-19, figures show – St Albans & Harpenden Review
Article feature image
Here’s how bullying, obesity can affect girls’ and boys’ mental health – Hindustan Times